HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuyoshi Azuma Selected Research

N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinal

12/2005Calpain may contribute to hereditary cataract formation in sheep.
7/2005Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia.
2/2002Involvement of calpain in hypoxia-induced damage in rat retina in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuyoshi Azuma Research Topics

Disease

10Hypoxia (Hypoxemia)
11/2020 - 02/2002
8Cataract (Cataracts)
03/2015 - 02/2002
5Dry Eye Syndromes (Dry Eye Syndrome)
01/2020 - 02/2007
3Autolysis
11/2020 - 07/2005
3Ganglion Cysts (Ganglion)
01/2020 - 01/2013
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2016 - 09/2009
3Inflammation (Inflammations)
07/2014 - 07/2004
3Retinal Degeneration
03/2007 - 10/2004
3Glaucoma
12/2006 - 07/2005
3Ischemia
12/2006 - 02/2002
2Retinal Diseases
11/2020 - 01/2017
2Parkinson Disease (Parkinson's Disease)
11/2016 - 07/2014
2Ocular Hypertension (Glaucoma, Suspect)
06/2014 - 05/2006
2Macular Degeneration (Age-Related Maculopathy)
11/2013 - 10/2009
2Conjunctivitis
08/2013 - 07/2004
1Fuchs' Endothelial Dystrophy
11/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016
1Vision Disorders (Hemeralopia)
10/2016
1Demyelinating Diseases (Demyelinating Disease)
10/2016
1Gliosis
10/2016
1Optic Neuritis (Retrobulbar Neuritis)
10/2016
1Wounds and Injuries (Trauma)
08/2015
1Corneal Diseases (Corneal Disease)
08/2015
1Uveitis
03/2015
1Multiple Sclerosis
07/2014
1Neuroblastoma
07/2014
1Choroidal Neovascularization
01/2014
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
08/2013
1Lissencephaly
01/2013
1Necrosis
10/2011
1Diabetic Retinopathy (Retinopathy, Diabetic)
09/2011
1Pathologic Neovascularization
10/2009
1Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2007
1Blindness (Hysterical Blindness)
12/2006
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
09/2005
1Muscular Diseases (Myopathy)
09/2005

Drug/Important Bio-Agent (IBA)

20CalpainIBA
11/2020 - 02/2002
11Retinaldehyde (Retinal)IBA
11/2020 - 02/2002
11calpain inhibitorsIBA
10/2016 - 02/2002
9SpectrinIBA
09/2015 - 02/2002
6((1S)- 1- ((((1S)- 1- benzyl- 3- cyclopropylamino- 2,3- di- oxopropyl)amino)carbonyl)- 3- methylbutyl)carbamic acid 5-methoxy-3-oxapentyl esterIBA
11/2020 - 03/2007
6CalciumIBA
10/2011 - 11/2002
5Peptide Hydrolases (Proteases)FDA Link
11/2020 - 07/2005
5Pharmaceutical PreparationsIBA
11/2016 - 04/2005
3CaspasesIBA
11/2020 - 09/2011
3Ophthalmic Solutions (Eye Drops)IBA
01/2017 - 12/2005
3Crystallins (Crystallin)IBA
03/2015 - 06/2002
3Proteins (Proteins, Gene)FDA Link
04/2013 - 07/2005
3N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinalIBA
12/2005 - 02/2002
3Protein Isoforms (Isoforms)IBA
10/2004 - 02/2002
2Caspase 3 (Caspase-3)IBA
11/2020 - 09/2011
2CytokinesIBA
11/2016 - 04/2013
2Cytoskeletal ProteinsIBA
07/2014 - 07/2005
2Glucose (Dextrose)FDA LinkGeneric
07/2005 - 11/2002
1Scopolamine (Hyoscine)FDA Link
01/2020
1N- (1- acetylpiperidin- 4- yl)- 4- fluorobenzamideIBA
01/2017
1AntigensIBA
10/2016
1Neurofilament ProteinsIBA
10/2016
1EnzymesIBA
09/2015
1AS 8IBA
09/2015
1Heptanol (1 Heptanol)IBA
08/2015
1Galectin 3 (LGALS3)IBA
08/2015
1Sodium Hydroxide (Caustic Soda)FDA Link
08/2015
1AntibodiesIBA
03/2015
1LubricantsIBA
07/2014
1RotenoneIBA
07/2014
1Cholinergic Agents (Cholinergics)IBA
07/2014
1EpitopesIBA
07/2014
1Immunomodulating AgentsIBA
07/2014
1hydroxide ionIBA
06/2014
1IntegrinsIBA
01/2014
1Retinal Pigments (Pigments, Visual)IBA
11/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013
1Phosphotransferases (Kinase)IBA
08/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2013
1dinitrophenyl-bovine serum albuminIBA
08/2013
1OvalbuminIBA
08/2013
1Conditioned Culture MediaIBA
08/2013
1Immunoglobulin E (IgE)IBA
08/2013
14(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxalineIBA
08/2013
1Janus Kinase InhibitorsIBA
08/2013
1Aluminum Hydroxide (Algeldrate)FDA Link
08/2013
1Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2013
1ethidium homodimerIBA
10/2011
1Fluorescein-5-isothiocyanate (FITC)IBA
10/2011
1Annexin A5IBA
10/2011
1ZincIBA
12/2009
1Calcimycin (A23187)IBA
12/2009
1Calcium IonophoresIBA
12/2009
1Lysine (L-Lysine)FDA Link
12/2009
1Myelin Basic ProteinIBA
09/2009
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2007
1VimentinIBA
12/2005

Therapy/Procedure

6Lenses
03/2015 - 02/2002
2Laser In Situ Keratomileusis (LASIK)
07/2014 - 02/2007
2Slit Lamp
12/2005 - 11/2002
1Immunomodulation
07/2014
1Intraperitoneal Injections
08/2013
1Surgical Amputation (Amputations)
08/2012
1Therapeutics
10/2009